fda glp-1 compounding enforcement october 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our fda glp-1 compounding enforcement news

At Bio.me, we use vegan-friendly natural flavors to help us capture the essence of real ingredients in a way that stays consistent and enjoyable every time you taste our products

40g protein, under 400 calories, packed with fiber to support digestion and satiety

Muscle pain is not a direct side effect of using Ozempic, but Ozempic could cause other things that result in body aches

The novel incretin agonist, named I-M-150847, promotes robust glucose-stimulated insulin exocytosis in cultured pancreatic beta cells

Discover how combining HRT and GLP-1 therapy helps women in perimenopause and menopause achieve better weight loss, improved metabolic health, and long-term wellness